JCI - Citations to Insight into the heterogeneity of breast cancer through next-generation sequencing

Citations to this article

Insight into the heterogeneity of breast cancer through next-generation sequencing

Hege G. Russnes, … , James Hicks, Anne-Lise Borresen-Dale

Hege G. Russnes, … , James Hicks, Anne-Lise Borresen-Dale

Published October 3, 2011
Citation Information: J Clin Invest. 2011;121(10):3810-3818. https://doi.org/10.1172/JCI57088.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2009	Total
Citations:	3	7	3	8	6	9	5	6	6	5	16	18	17	11	1	1	122

Citation information

Citations to this article (123)

Title and authors	Publication	Year
Forcing the code: tension modulates signaling to drive morphogenesis and malignancy Narain R, Muncie-Vasic JM, Weaver VM	Genes & Development	2025
Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy Ma J, Wang H, Gui Z, Yang Y	Frontiers in Oncology	2025
Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer Ye Z, Yuan J, Hong D, Xu P, Liu W	Frontiers in Immunology	2025
A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data Qiao Y, Huang X, Moos PJ, Ahmann JM, Pomicter AD, Deininger MW, Byrd JC, Woyach JA, Stephens DM, Marth GT	Genome research	2024
(18)F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy. Diwanji D, Onishi N, Hathi DK, Lawhn-Heath C, Kornak J, Li W, Guo R, Molina-Vega J, Seo Y, Flavell RR, Heditsian D, Brain S, Esserman LJ, Joe BN, Hylton NM, Jones EF, Ray KM		2024
Evolution of chromosome-arm aberrations in breast cancer through genetic network rewiring. Kuzmin E, Baker TM, Lesluyes T, Monlong J, Abe KT, Coelho PP, Schwartz M, Del Corpo J, Zou D, Morin G, Pacis A, Yang Y, Martinez C, Barber J, Kuasne H, Li R, Bourgey M, Fortier AM, Davison PG, Omeroglu A, Guiot MC, Morris Q, Kleinman CL, Huang S, Gingras AC, Ragoussis J, Bourque G, Van Loo P, Park M	Cell Reports	2024
[18F]F-Poly(ADP-Ribose) Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology Ndlovu H, Lawal IO, Mdanda S, Kgatle MM, Mokoala KM, Al-Ibraheem A, Sathekge MM	Journal of Clinical Medicine	2024
Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment‐naïve breast cancer Chen S, Tse K, Lu Y, Chen S, Tian Y, Tan KT, Li C	Cancer Medicine	2024
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients. Linders DGJ, Bijlstra OD, Fallert LC, Dekker-Ensink NG, March TL, Pool M, Walker E, Straight B, Basilion JP, Bogyo M, Burggraaf J, Hilling DE, Vahrmeijer AL, Kuppen PJK, Crobach ASLP	Molecular imaging and biology	2024
Texture analysis of CT colonography to develop a novel imaging biomarker for the management of colorectal cancer Mamiya H, Tochigi T, Hayano K, Ohira G, Imanishi S, Maruyama T, Kurata Y, Takahashi Y, Hirata A, Matsubara H	Annals of Gastroenterological Surgery	2024
A Pilot Study on Biochemical Profile of Follicular Fluid in Breast Cancer Patients. Castiglione Morelli MA, Iuliano A, Matera I, Viggiani L, Schettini SCA, Colucci P, Ostuni A	Metabolites	2023
Breast Cancer Statistics in Korea, 2019. Choi JE, Kim Z, Park CS, Park EH, Lee SB, Lee SK, Choi YJ, Han J, Jung KW, Kim HJ, Kim HA	Journal of Breast Cancer	2023
Omics Technologies Improving Breast Cancer Research and Diagnostics Orsini A, Diquigiovanni C, Bonora E	International journal of molecular sciences	2023
Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A	BioMed Research International	2022
A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer Liu J, Zhu J, Wang X, Zhou Z, Liu H, Zhu D	Frontiers in Molecular Biosciences	2022
Transcriptional Factor Repertoire of Breast Cancer in 3D Cell Culture Models Özkan H, Öztürk DG, Korkmaz G	Cancers	2022
MOCA for Integrated Analysis of Gene Expression and Genetic Variation in Single Cells Huzar J, Kim H, Kumar S, Miura S	Frontiers in Genetics	2022
Fate decisions of breast cancer stem cells in cancer progression Xu H, Zhang F, Gao X, Zhou Q, Zhu L	Frontiers in Oncology	2022
High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues. Mehta V, Suman P, Chander H	Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico	2022
Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer. Xi Y, Li T, Xi Y, Zeng X, Miao Y, Guo R, Zhang M, Li B	Cancer Cell International	2022
Rational Approach to Finding Genes Encoding Molecular Biomarkers: Focus on Breast Cancer Schneider N, Reed E, Kamel F, Ferrari E, Soloviev M	Genes & development	2022
Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis M Liu, F Mo, X Song, Y He, Y Yuan, J Yan, Y Yang, J Huang, S Zhang	PeerJ	2021
A Bayesian nonparametric model for inferring subclonal populations from structured DNA sequencing data S He, A Schein, V Sarsani, P Flaherty	The Annals of Applied Statistics	2021
Deregulation of Transcriptional Enhancers in Cancer FM Azad, Y Atlasi	Cancers	2021
Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment Y Wang, Y Zhang, Y Huang, C Chen, X Zhang, Y Xing, Y Gu, M Zhang, L Cai, S Xu, B Sun	Theranostics	2021
An adaptive method of defining negative mutation status for multi-sample comparison using next-generation sequencing N Hutson, F Zhan, J Graham, M Murakami, H Zhang, S Ganaparti, Q Hu, L Yan, C Ma, S Liu, J Xie, L Wei	BMC Medical Genomics	2021
Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies N Zhao, J Rosen	Seminars in Cancer Biology	2021
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View M Labbozzetta, M Notarbartolo, P Poma	International journal of molecular sciences	2020
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments U Testa, G Castelli, E Pelosi	Medical Sciences	2020
Bioinformatics and Computational Tools for Next-Generation Sequencing Analysis in Clinical Genetics R Pereira, J Oliveira, M Sousa	Journal of Clinical Medicine	2020
Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors E Kim, M Kim, K So, YS Park, CG Woo, SH Hyun	Cancer Cell International	2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testing EJ Adams, S Asad, R Reinbolt, KA Collier, M Abdel-Rasoul, S Gillespie, JL Chen, MA Cherian, AM Noonan, S Sardesai, J VanDeusen, R Wesolowski, N Williams, CL Shapiro, ER Macrae, R Pilarski, AE Toland, L Senter, B Ramaswamy, CN Lee, MB Lustberg, DG Stover	BMC Cancer	2020
Genome-Wide Estrogen Receptor Activity in Breast Cancer AM Farcas, S Nagarajan, S Cosulich, JS Carroll	Endocrinology	2020
Autophagy Inhibition Induces the Secretion of Macrophage Migration Inhibitory Factor (MIF) with Autocrine and Paracrine Effects on the Promotion of Malignancy in Breast Cancer I Cotzomi-Ortega, A Rosas-Cruz, D Ramírez-Ramírez, J Reyes-Leyva, M Rodriguez-Sosa, P Aguilar-Alonso, P Maycotte	Biology : open access journal	2020
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy B Judmann, D Braun, B Wängler, R Schirrmacher, G Fricker, C Wängler	Pharmaceuticals (Basel, Switzerland)	2020
Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes YS Chun, T Mizuno, JM Cloyd, MJ Ha, K Omichi, CW Tzeng, TA Aloia, NT Ueno, HM Kuerer, CH Barcenas, JN Vauthey	European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology	2020
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol EF Jones, KM Ray, W Li, AJ Chien, RA Mukhtar, LJ Esserman, BL Franc, Y Seo, MH Pampaloni, BN Joe, NM Hylton	npj Breast Cancer	2019
The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models Cleris, Daidone, Fina, Cappelletti	Cells	2019
Paclitaxel Response Can Be Predicted With Interpretable Multi-Variate Classifiers Exploiting DNA-Methylation and miRNA Data A Bomane, A Gonçalves, PJ Ballester	Frontiers in Genetics	2019
A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer CI DeVette, H Gundlapalli, SC Lai, CP McMurtrey, AR Hoover, HR Gurung, WR Chen, AL Welm, WH Hildebrand	OncoImmunology	2019
Dhaka: variational autoencoder for unmasking tumor heterogeneity from single cell genomic data Rashid S, Shah S, Bar-Joseph Z, Pandya R	Bioinformatics	2019
Overview on Clinical Relevance of Intra-Tumor Heterogeneity G Stanta, S Bonin	Frontiers in Medicine	2018
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor S Park, S Ha, SH Lee, JC Paeng, B Keam, TM Kim, DW Kim, DS Heo, JG Gelovani	PloS one	2018
Characterization of tumor heterogeneity by latent haplotypes: a sequential Monte Carlo approach OE Ogundijo, X Wang	PeerJ	2018
Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers T Guo, L Li, Q Zhong, NJ Rupp, K Charmpi, CE Wong, U Wagner, JH Rueschoff, W Jochum, CD Fankhauser, K Saba, C Poyet, PJ Wild, R Aebersold, A Beyer		2018
Single drug biomarker prediction for ER− breast cancer outcome from chemotherapy YZ Chen, Y Kim, HH Soliman, GG Ying, JK Lee	Endocrine Related Cancer	2018
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation: Breast cancer risk by grade and proliferation M Abubakar, J Chang-Claude, HR Ali, N Chatterjee, P Coulson, F Daley, F Blows, J Benitez, RL Milne, H Brenner, C Stegmaier, A Mannermaa, A Rudolph, P Sinn, FJ Couch, P Devilee, RA Tollenaar, C Seynaeve, J Figueroa, J Lissowska, S Hewitt, MJ Hooning, A Hollestelle, R Foekens, LB Koppert, kConFab Investigators, MK Bolla, Q Wang, ME Jones, MJ Schoemaker, R Keeman, DF Easton, AJ Swerdlow, ME Sherman, MK Schmidt, PD Pharoah, M Garcia-Closas	International Journal of Cancer	2018
Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression K Roarty, AD Pfefferle, CJ Creighton, CM Perou, JM Rosen	Oncogene	2017
A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans K Goebel, ND Merner	Veterinary Medicine and Science	2017
Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers T Kato, JH Park, K Kiyotani, Y Ikeda, Y Miyoshi, Y Nakamura	Oncotarget	2017
Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq Y Shen, L Bu, R Li, Z Chen, F Tian, N Lu, Q Ge, Y Bai, Z Lu	Oncotarget	2017
Progress and challenges of sequencing and analyzing circulating tumor cells Z Zhu, S Qiu, K Shao, Y Hou	Cell Biology and Toxicology	2017
Study of the tumor microenvironment during breast cancer progression R Eftekhari, R Esmaeili, R Mirzaei, K Bidad, S Lima, M Ajami, H Shirzad, J Hadjati, K Majidzadeh-A	Cancer Cell International	2017
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy GH Huang, QF Xu, YH Cui, N Li, XW Bian, SQ Lv	Cancer Science	2016
Tumour heterogeneity: principles and practical consequences G Stanta, SW Jahn, S Bonin, G Hoefler	Virchows Archiv	2016
Bayesian inference for intratumour heterogeneity in mutations and copy number variation J Lee, P Müller, S Sengupta, K Gulukota, Y Ji	Applied Statistics	2016
Cancer Cell Fusion: Mechanisms Slowly Unravel F Noubissi, B Ogle	International journal of molecular sciences	2016
Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study J Schmitz, J Schwab, J Schwenck, Q Chen, L Quintanilla-Martinez, M Hahn, B Wietek, N Schwenzer, A Staebler, U Kohlhofer, OH Aina, NE Hubbard, G Reischl, AD Borowsky, S Brucker, K Nikolaou, C Fougère, RD Cardiff, BJ Pichler, AM Schmid	Cancer research	2016
The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients N Egeland, S Lunde, K Jonsdottir, T Lende, D Cronin-Fenton, B Gilje, E Janssen, H Søiland	International journal of molecular sciences	2015
Clinical management of breast cancer heterogeneity D Zardavas, A Irrthum, C Swanton, M Piccart	Nature Reviews Clinical Oncology	2015
Molecular characterization and targeted therapeutic approaches in breast cancer A Toss, M Cristofanilli	Breast Cancer Research	2015
Mutant Allele Tumor Heterogeneity (MATH) and Head and Neck Squamous Cell Carcinoma JW Rocco	Head and Neck Pathology	2015
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer CN Johnstone, YE Smith, Y Cao, AD Burrows, RS Cross, X Ling, RP Redvers, JP Doherty, BL Eckhardt, AL Natoli, CM Restall, E Lucas, HB Pearson, S Deb, KL Britt, A Rizzitelli, J Li, JH Harmey, N Pouliot, RL Anderson	Disease models & mechanisms	2015
Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1 LV Rhodes, CR Tate, VT Hoang, HE Burks, D Gilliam, EC Martin, S Elliott, DB Miller, A Buechlein, D Rusch, H Tang, KP Nephew, ME Burow, BM Collins-Burow	Oncogenesis	2015
Molecular subtyping for clinically defined breast cancer subgroups X Zhao, EA Rødland, R Tibshirani, S Plevritis	Breast Cancer Research	2015
In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival S Bonin, D Pracella, R Barbazza, S Sulfaro, G Stanta	Virchows Archiv	2015
Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy IA Voutsadakis	World journal of clinical oncology	2015
Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia Z Weng, N Spies, SX Zhu, DE Newburger, D Kashef-Haghighi, S Batzoglou, A Sidow, RB West	Genome Medicine	2015
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer RA Hutchinson, RA Adams, DG McArt, M Salto-Tellez, B Jasani, PW Hamilton	Journal of Translational Medicine	2015
Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis D Ellsworth, R Ellsworth, A Toro, H Blackburn, A Decewicz, B Deyarmin, K Mamula, N Costantino, C Shriver, J Hooke	Cancer Growth and Metastasis	2015
Cell injury, retrodifferentiation and the cancer treatment paradox J Uriel	Tumor Biology	2015
Ultra-fast local-haplotype variant calling using paired-end DNA-sequencing data reveals somatic mosaicism in tumor and normal blood samples S Sengupta, K Gulukota, Y Zhu, C Ober, K Naughton, W Wentworth-Sheilds, Y Ji	Nucleic Acids Research	2015
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology E Kirkizlar, B Zimmermann, T Constantin, R Swenerton, B Hoang, N Wayham, JE Babiarz, Z Demko, RJ Pelham, S Kareht, AL Simon, KN Jinnett, M Rabinowitz, S Sigurjonsson, M Hill	Translational oncology	2015
Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development Aswad L, Yenamandra SP, Ow GS, Grinchuk O, Ivshina AV, Kuznetsov VA	Oncotarget	2015
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis T Wang, DM Gilkes, N Takano, L Xiang, W Luo, CJ Bishop, P Chaturvedi, JJ Green, GL Semenza	Proceedings of the National Academy of Sciences	2014
Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells D Samanta, DM Gilkes, P Chaturvedi, L Xiang, GL Semenza	Proceedings of the National Academy of Sciences	2014
Allogeneic tumor cell vaccines: The promise and limitations in clinical trials S Srivatsan, JM Patel, EN Bozeman, IE Imasuen, S He, D Daniels, P Selvaraj	Human Vaccines & Immunotherapeutics	2014
Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer T Jiang, W Shi, R Natowicz, SN Ononye, VB Wali, Y Kluger, L Pusztai, C Hatzis	BMC Genomics	2014
Combining functional genomics strategies identifies modular heterogeneity of breast cancer intrinsic subtypes N Pouladi, R Cowper-Sallari, JH Moore	BioData mining	2014
Integrative gene set analysis of multi-platform data with sample heterogeneity J Hu, JY Tzeng	Bioinformatics	2014
Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment M Renovanz, EL Kim	Frontiers in Oncology	2014
A New Toolbox for Assessing Single Cells K Tsioris, AJ Torres, TB Douce, JC Love	Annual Review of Chemical and Biomolecular Engineering	2014
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences NS Fox, MH Starmans, S Haider, P Lambin, PC Boutros	BMC bioinformatics	2014
Changing genetic paradigms: creating next-generation genetic databases as tools to understand the emerging complexities of genotype/phenotype relationships B Gottlieb, LK Beitel, M Trifiro	Human genomics	2014
PARP inhibitor reduces proliferation and increases apoptosis in breast cancer cells Y Shi, F Zhou, F Jiang, H Lu, J Wang, C Cheng	Chinese Journal of Cancer Research	2014
Identification of structural variation in mouse genomes TM Keane, K Wong, DJ Adams, J Flint, A Reymond, B Yalcin	Frontiers in Genetics	2014
Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease AJ Knox, AL Scaling, MP Pinto, BS Bliesner, JM Haughian, HA Abdel-Hafiz, KB Horwitz	Breast Cancer Research	2014
The multitude of molecular analyses in cancer: the opening of Pandora’s box HG Russnes, PE Lønning, AL Børresen-Dale, OC Lingjærde	Genome biology	2014
Cancer stem cells - the current status of an old concept: literature review and clinical approaches L Fulawka, P Donizy, A Halon	Biological research	2014
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis M Rytelewski, JG Tong, A Buensuceso, HS Leong, SM Vareki, R Figueredo, CD Cresce, SY Wu, SM Herbrich, KA Baggerly, L Romanow, T Shepherd, BJ Deroo, AK Sood, AF Chambers, M Vincent, PJ Ferguson, J Koropatnick	Molecular Oncology	2014
Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine. Wright GM, Do H, Weiss J, Alam NZ, Rathi V, Walkiewicz M, John T, Russell PA, Dobrovic A	Oncotarget	2014
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Wheler JJ, Moulder SL, Naing A, Janku F, Piha-Paul SA, Falchook GS, Zinner R, Tsimberidou AM, Fu S, Hong DS, Atkins JT, Yelensky R, Stephens PJ, Kurzrock R	Oncotarget	2014
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases N Strbo, A Garcia-Soto, TH Schreiber, ER Podack	Immunologic Research	2013
Tumour heterogeneity and immune-modulation M Jamal-Hanjani, E Thanopoulou, KS Peggs, SA Quezada, C Swanton	Current Opinion in Pharmacology	2013
Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells A Papi, G Storci, T Guarnieri, SD Carolis, S Bertoni, N Avenia, A Sanguinetti, A Sidoni, D Santini, C Ceccarelli, M Taffurelli, M Orlandi, M Bonafé	PloS one	2013
Molecular and Cellular Heterogeneity in Breast Cancer AG Rivenbark, SM OConnor, WB Coleman	The American Journal of Pathology	2013
Emerging targeted agents in metastatic breast cancer D Zardavas, J Baselga, M Piccart	Nature Reviews Clinical Oncology	2013
High intra-tumor genetic heterogeneity is related to worse outcome in head and neck squamous cell carcinoma EA Mroz, AD Tward, CR Pickering, JN Myers, RL Ferris, JW Rocco	Cancer	2013
Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified MV Zavyalova, EV Denisov, LA Tashireva, TS Gerashchenko, NV Litviakov, NA Skryabin, SV Vtorushin, NS Telegina, EM Slonimskaya, NV Cherdyntseva, VM Perelmuter	BioResearch Open Access	2013
Next generation sequencing in cancer research and clinical application D Shyr, Q Liu	Biological Procedures Online	2013
Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Invasive Ductal Carcinoma of the Breast: The Impact on Prognosis and Correlation to Clinicopathologic Features JH Kim, TH Baek, HS Yim, KH Kim, SH Jeong, HB Kang, S Oh, HG Lee, JW Kim, KD Kim	Pathology & Oncology Research	2013
Cancer heterogeneity: implications for targeted therapeutics R Fisher, L Pusztai, C Swanton	British Journal of Cancer	2013
A multi-site feasibility study for personalized medicine in canines with Osteosarcoma NR Monks, DM Cherba, SG Kamerling, H Simpson, AW Rusk, D Carter, E Eugster, M Mooney, R Sigler, M Steensma, T Grabinski, KR Marotti, CP Webb	Journal of Translational Medicine	2013
STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice F Meyer-Losic, SP Newman, JM Day, MJ Reed, PG Kasprzyk, A Purohit, PA Foster	PloS one	2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, JP Blaydes, K Brennan, NJ Brown, HE Bryant, NJ Bundred, JM Burchell, AM Campbell, JS Carroll, RB Clarke, CE Coles, GJ Cook, A Cox, NJ Curtin, LV Dekker, IS Silva, SW Duffy, DF Easton, DM Eccles, DR Edwards, J Edwards, D Evans, DF Fenlon, JM Flanagan, C Foster, WM Gallagher, M Garcia-Closas, JM Gee, AJ Gescher, V Goh, AM Groves, AJ Harvey, M Harvie, BT Hennessy, S Hiscox, I Holen, SJ Howell, A Howell, G Hubbard, N Hulbert-Williams, MS Hunter, B Jasani, LJ Jones, TJ Key, CC Kirwan, A Kong, IH Kunkler, SP Langdon, MO Leach, DJ Mann, JF Marshall, L Martin, SG Martin, JE Macdougall, DW Miles, WR Miller, JR Morris, SM Moss, P Mullan, R Natrajan, JP O'Connor, R O'Connor, C Palmieri, PD Pharoah, EA Rakha, E Reed, SP Robinson, E Sahai, JM Saxton, P Schmid, MJ Smalley, V Speirs, R Stein, J Stingl, CH Streuli, AN Tutt, G Velikova, RA Walker, CJ Watson, KJ Williams, LS Young, AM Thompson	Breast Cancer Research	2013
Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality" M Rytelewski, PJ Ferguson, SM Vareki, R Figueredo, M Vincent, J Koropatnick	Molecular Therapy — Nucleic Acids	2013
Elite model for the generation of induced pluripotent cancer cells (iPCs) J Lai, CM Kong, D Mahalingam, X Xie, X Wang	PloS one	2013
The optimal approach to early breast cancer Wyld L	EJC Supplements	2013
Ovarian Cancer Biomarker Discovery Based on Genomic Approaches Lee JY, Kim HS, Suh DH, Kim MK, Chung HH, Song YS	Journal of Cancer Prevention	2013
Intra-tumour heterogeneity: a looking glass for cancer? A Marusyk, V Almendro, K Polyak	Nature Reviews Cancer	2012
Whole genome sequencing for lung cancer M Daniels, F Goh, CM Wright, KB Sriram, V Relan, BE Clarke, EE Duhig, RV Bowman, IA Yang, KM Fong	Journal of Thoracic Disease	2012
Progress in breast cancer research K Polyak, PK Vogt	Proceedings of the National Academy of Sciences	2012
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells J Węsierska-Gądek, N Zulehner, F Ferk, A Składanowski, O Komina, M Maurer	Biochemical Pharmacology	2012
What is personalized medicine and what should it replace? DC Whitcomb	Nature Reviews Gastroenterology & Hepatology	2012
Epigenetics advancing personalized nanomedicine in cancer therapy S Liu	Advanced Drug Delivery Reviews	2012
Next-generation sequencing: application in liver cancer-past, present and future? JU Marquardt, JB Andersen	Biology : open access journal	2012
Effective normalization for copy number variation detection from whole genome sequencing A Janevski, V Varadan, S Kamalakaran, N Banerjee, N Dimitrova	BMC Genomics	2012
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells JW Ruan, YC Liao, I Lua, MH Li, CY Hsu, JH Chen	Breast Cancer Research	2012
Biomarkers in Breast Cancer – An Update M Schmidt, P Fasching, M Beckmann, H Kölbl	Geburtshilfe und Frauenheilkunde	2012
Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours Walker LC, Krause L, Spurdle AB, Waddell N	Breast Cancer Research and Treatment	2012
Heterogeneity in breast cancer Kornelia Polyak	Journal of Clinical Investigation	2011
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
The potential for liquid biopsies in the precision medical treatment of breast cancer Victoria A. Forte, Dany K. Barrak, Mostafa Elhodaky, Lily Tung, Anson Snow, Julie E. Lang	Cancer biology & medicine

Advertisement